Bepharco stands out not only for its high-quality products and international partnerships but also as a pioneer in nurturing talent, placing people at the heart of sustainable development and community responsibility.
A Legacy Spanning Six Decades
Founded in 1963 as the Pharmaceutical Preparation Department of the Ben Tre People’s Health Bureau, Bepharco has weathered numerous challenges to become a trusted pharmaceutical enterprise. Today, it boasts a GMP-WHO-certified factory, a modern production system, and a distribution network spanning 34 provinces. Bepharco currently supplies over 250 products to 35,000 customers across hospitals, clinics, and pharmacies nationwide.
Guided by the mission to “Deliver the best products for health, enhance quality of life, and uphold community responsibility,” Bepharco continually innovates production technology, refines management processes, and elevates pharmaceutical quality. To date, Bepharco has proudly brought Vietnamese pharmaceuticals to the global stage, affirming its commitment to quality and contributing to Vietnam’s rise in the new era.

Vision for Sustainable Development
In an era of deep integration, Bepharco aims to become one of Vietnam’s top five pharmaceutical distributors, synonymous with trust, quality, and dedication. Its development strategy rests on three pillars:
Product Quality: Investing in cutting-edge technology, researching advanced treatment trends, and fostering international collaborations to deliver high-quality pharmaceuticals to consumers. With unwavering dedication, Bepharco continuously invests in research, product development, and enhanced after-sales services, caring for customers’ physical, mental, and professional well-being. On April 5, 2025, in Hanoi, the flagship product Cam Xuyen Huong was awarded the Golden Brand – Vietnam’s Number One Brand 2025 in Pharmaceuticals, a testament to Bepharco’s commitment to knowledge and people-centric values.
Innovation, Research, and Global Integration: Bepharco focuses on strengthening R&D capabilities and forging strategic partnerships with global pharmaceutical leaders to introduce new products with superior efficacy, minimal side effects, and cost-effectiveness. Each step reflects a vision of global integration, embracing advanced knowledge and creating sustainable value for Vietnam’s pharmaceutical industry. Additionally, Bepharco engages in M&A activities with manufacturing plants, ensuring a foundation of high-quality products for public health.
Expanding International Markets: With a robust foundation of three manufacturing plants—spanning traditional medicine, chemical pharmaceuticals, and functional foods—Bepharco proactively researches, develops new products, and innovates formulation technologies and packaging. This enables Bepharco to confidently meet the stringent demands of both domestic and international markets. To date, Bepharco has signed supply contracts with over 34 partners across 19 countries, marking the initial steps in bringing Vietnamese pharmaceuticals to the world and showcasing Vietnamese mastery of high-quality drug manufacturing and supply.

Mr. Hoang Xuan An, Deputy General Director of Ben Tre Pharmaceutical Joint Stock Company, receives the Vietnam’s Number One Brand 2025 award in Pharmaceuticals.
Nurturing Future Pharmacists
Recognizing that people are the cornerstone of sustainable development, Bepharco has established strategic partnerships with universities and medical colleges to provide practical training, internships, and scholarships. This initiative not only reflects social responsibility but also the leadership’s passion for cultivating the next generation of pharmacists. By equipping young talents with solid expertise, Bepharco empowers them to contribute to Vietnam’s pharmaceutical advancement and embrace global medical innovations.
Conclusion
Bepharco’s journey is a testament to its unwavering commitment to quality and strategic vision, blending business growth with social responsibility. With modern management technology, extensive international collaborations, and a sustainable human resource strategy, Bepharco leads the way in community healthcare.
Bepharco – Quality Medicine, Better Health
Website: https://bepharco.com/
Hotline: 1800 1745
Zalo OA: Dược Bến Tre Bepharco
Why Vietnamese Investors Are Still Locked Out of Crypto Assets: State Securities Commission Explains
According to regulatory authorities, restricting cryptocurrency transactions solely to foreign investors is a cautious measure designed to safeguard domestic investors and mitigate risks during the initial phase.
Vietnam Attracts Over $31.5 Billion in FDI in the First 10 Months of 2025
According to the General Statistics Office, as of October 31, 2025, Vietnam’s total registered foreign direct investment (FDI) reached $31.52 billion, reflecting newly registered capital, adjusted capital, and foreign investors’ contributions and share purchases. This figure represents a 15.6% increase compared to the same period last year.
International Financial Center: Fueling Vietnam’s New Growth Cycle
Vietnam boasts a robust fiscal buffer and a public debt level well within safe limits, enabling the government to ramp up strategic public investment. This investment is directed toward bolstering digital economic infrastructure and modernizing financial institutions, fostering a more resilient and dynamic economy.
EuroCham Chairman: Vietnam Poised to Join the Top 15 Global Economies
Vietnam stands at a unique crossroads, poised for unprecedented growth. With an extensive network of Free Trade Agreements (FTAs), a rapidly expanding manufacturing capacity, and an economy renowned for its resilience, the country is primed to surge ahead. As the Chairman of EuroCham observes, these factors collectively position Vietnam as a formidable player in the global arena, ready to capitalize on its strengths and chart a course toward remarkable advancement.







































